Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
US2016312274A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016312274-A1 |
| Application number | US-201615136774-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 22, 2016 |
| Priority date | Apr 24, 2015 |
| Publication date | Oct 27, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for performing digital polymerase chain reaction (dPCR) is provided. The method includes partitioning a biological sample volume including a plurality of target nucleic acids into a plurality of partitions, where at least one partition includes at least one target nucleic acid. The method further includes determining a model for volume variation of the plurality of partitions and determining a number of partitions including at least one target nucleic acid. The method includes generating a concentration of target nucleic acids in the biological sample based on the model for volume variation and the fraction of partitions including at least one target nucleic acid.
Opening claim text (preview).
What is claimed is: 1 . A method for performing digital polymerase chain reaction (dPCR), the method comprising: partitioning a biological sample volume including a plurality of target nucleic acids into a plurality of partitions, wherein at least one partition includes at least one target nucleic acid; determining a model for volume variation of the plurality of partitions; determining a number of partitions including at least one target nucleic acid; and generating a concentration of target nucleic acids in the biological sample based on the model for volume variation and the fraction of partitions including at least one target nucleic acid. 2 . The method of claim 1 , wherein the concentration of target nucleic acids in the biological sample is determined by using the equation: C = v 0 - v 0 2 + 2 σ 2 ln P ( neg ) σ 2 . 3 . The method of claim 1 , wherein the concentration of target nucleic acids in the biological sample is determined by using the equation: P ( neg ) = erfc [ - 1 2 ( v 0 σ - C σ ) ] erfc [ - 1 2 ( v 0 σ ) ] - Cv 0 + 1 2 σ 2 C 2 4 . The method of claim 1 , further comprising: amplifying the target nucleic acids to determine the number of partitions including at least one target nucleic acid. 5 . The method of claim 1 , wherein the model for volume variation is: P ( neg ) = erfc [ - 1 2 ( v 0 σ - C σ ) ] erfc [ - 1 2 (
Quantitative amplification · CPC title
for evaluating statistical data {, e.g. average values, frequency distributions, probability functions, regression analysis (forecasting specially adapted for a specific administrative, business or logistic context G06Q10/04)} · CPC title
ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.